On October 30, DaVita HealthCare Partners recorded an Overnight fall of 8.94%, trading at $179.91/share, with turnover of $355.93. The move followed a post-earnings reaction, even though quarterly results exceeded market expectations.
For the quarter ended September 30, adjusted EPS was $3.82, above estimates of $3.57 to $3.61 and up from $2.51 a year earlier, while revenue rose to $3.58 billion from $3.42 billion, ahead of expectations near $3.52 billion. However, the company only lifted its full-year adjusted EPS guidance to $14.30-$15.20 from $14.10-$15.20, leaving the upper end unchanged and keeping the midpoint close to consensus expectations. A separate filing also showed DaVita HealthCare Partners repurchased 382,563 shares from Berkshire Hathaway.
(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)
Comments